A meta-analysis of randomized trials supports intensive blood pressure lowering in chronic kidney disease (CKD) not on dialysis.

A trial compared perioperative and oncologic outcomes after 2 different en bloc resection techniques for a single small nonmuscle-invasive bladder tumor.

Results from the trial showed that adding sotatercept-csrk to background therapy reduced the risk of clinical worsening events by 76% in adult patients with PAH diagnosed within the previous year.

Intervention in addition to standard antihypertensive treatment yields significantly lower MAP values at 15 minutes.

Positive anti-nephrin results did not explain all recurrences, indicating that other factors also play a role.

Workplace violence is highly prevalent across emergency care systems worldwide, according to a study published online Sept. 24 in the European Journal of Emergency Medicine to coincide with the annual ...

The patient developed rapidly progressive kidney disease despite multiple immunosuppressive therapies and plasma exchange.

Classical and collapsing patterns accounted for most de novo FSGS lesions in kidney allografts, which frequently showed chronic tubulointerstitial injury.

Pulmonary hypertension was present in the majority of both groups, affecting 60.7% of patients with PPF and 63.8% of those with IPF.

Patients with PAH had significant regional hypoperfusion, mainly in the frontal gyri, right hippocampus, and insula, compared with healthy people.

In national prospective study, 2.9 percent of those undergoing anesthesia reported receiving GLP-1 receptor agonist.

Functional decline begins many years before clinically apparent cardiovascular disease (CVD) events, according to a study published online Sept. 23 in JAMA Cardiology. Aung Zaw Zaw Phyo, Ph.D., from ...